Northern Utah Associates
Ogden, Utah, United States
Cardiologist in Washington Terrace, Utah
425 E 5350 S Suite 400, Ogden, UT 84405
About Northern Utah Associates
"Our expert cardiologists provide services like angioplasty, echocardiograms, stress tests, pacemaker implants and much more."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Genentech, Inc.
7
Bristol-Myers Squibb
5
Celgene
2
Hoffmann-La Roche
2
Millennium Pharmaceuticals, Inc.
2
Novartis Pharmaceuticals
2
AVEO Pharmaceuticals, Inc.
1
Agennix
1
CTI BioPharma
1
Celgene Corporation
1
Eisai Inc.
1
Clinical Trials at Northern Utah Associates
During the past decade, Northern Utah Associates conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 15 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
2000-12-04
2014-03-17
Completed
2,104
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
2003-02-01
Completed
1,168
Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer
2004-09-01
2007-01-01
Completed
300
First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
2007-01-01
2008-01-01
Completed
34
Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
2007-02-01
2009-12-01
Terminated
344
A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
2007-05-01
2008-12-01
Terminated
26
Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone
2007-06-01
2013-03-01
Completed
502
A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer
2007-07-01
2009-06-01
Completed
112
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Northern Utah Associates" #1 sponsor was "Genentech, Inc." with 7 trials, followed by "Bristol-Myers Squibb" with 5 trials
sponsored, "Celgene" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Millennium Pharmaceuticals, Inc."
with 2 trials sponsored. Other sponsors include 12 different institutions and
companies that sponsored additional 21 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Northern Utah Associates"
#1 collaborator was "AbbVie" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Northern Utah Associates
According to Clinical.Site data, the most researched conditions in "Northern Utah Associates" are
"Breast Cancer" (9 trials), "Multiple Myeloma" (5 trials), "Colorectal Cancer" (4 trials), "Chronic Lymphocytic Leukemia" (2 trials) and "Metastatic Breast Cancer" (2 trials). Many other conditions were trialed in "Northern Utah Associates" in a lesser frequency.
Clinical Trials Intervention Types at Northern Utah Associates
Most popular intervention types in "Northern Utah Associates" are "Drug" (32 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (5 trials), "Paclitaxel" (5 trials), "Placebo" (5 trials), "Dexamethasone" (4 trials) and "Elotuzumab" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Northern Utah Associates
The vast majority of trials in "Northern Utah Associates" are
25 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Northern Utah Associates
Currently, there are NaN active trials in "Northern Utah Associates".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 24 completed trials in Northern Utah Associates,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Northern Utah Associates, 0 "Phase 1"
clinical trials were conducted, 14 "Phase 2" clinical
trials and 17 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".